VistaGen Therapeutics Stock Discussion

$VistaGen Therapeutics(VTGN.US)$ Reuters· just
Vistagen Broadens Ph80 Global Intellectual Property Portfolio With New Patents for the Treatment of Migraine

$VistaGen Therapeutics(VTGN.US)$
VistaGen Therapeutics GAAP EPS of -$1.52 misses by $1.16, revenue of $1.06M beats by $0.86M
Jun. 11, 2024 4:23 PM ETVistagen Therapeutics, Inc. (VTGN) StockBy: Mary Christine Joy, SA News Editor
VistaGen Therapeutics press release (NASDAQ:VTGN): Q4 GAAP EPS of -$1.52 misses by $1.16.
Revenue of $1.06M (vs. -$0.23M last year)  beats by $0.86M.
Shares +0.8%.
Registration-directed fasedienol PALISADE Phase 3 program for the acute treatment of social anxiety disorder...

$VistaGen Therapeutics(VTGN.US)$VistaGen Therapeutics GAAP EPS of -$1.52 misses by $1.16, revenue of $1.06M beats by $0.86M
Vistagen Reports FY24 Net Loss Of $(29.4)M Vs $(59.2)M Last Year

$VistaGen Therapeutics(VTGN.US)$ anyone holding?

$Faraday Future Intelligent Electric Inc.(FFIE.US)$ $VistaGen Therapeutics(VTGN.US)$ another 1000% stock player potentially

$VistaGen Therapeutics(VTGN.US)$ Vistagen Announces Positive Results From Phase 2a Pilot Study of Ph15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue.                           Vistagen Therapeutics Inc: Ph15 Was Safe and Well-Tolerated With an Adverse Event Profile Similar to Placebo

$VistaGen Therapeutics(VTGN.US)$
238k shares bought 5.4

$VistaGen Therapeutics(VTGN.US)$ any news?

$VistaGen Therapeutics(VTGN.US)$ sian ah